Mr Charles Buck > McDermott Will & Emery LLP > Boston, United States > Lawyer Profile
McDermott Will & Emery LLP Offices
28 STATE STREET
BOSTON, MA 02109-1775
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Mr Charles Buck
Work Department
Healthcare
Position
Charles (Charlie) R. Buck advises healthcare enterprises on complex transactions and regulatory compliance. He represents a wide range of clients, including proprietary and tax-exempt hospital systems, academic medical centers and faculty practice groups, accountable care organizations, and health maintenance organizations (HMOs) and other health insurers. Charlie is partner-in-charge of the Firm’s Boston Health Industry Advisory Practice Group.
Charlie provides legal counsel and solutions in connection with mergers and acquisitions, joint ventures, strategic affiliations, conversions to tax-exempt status, and other transactional matters. He advises clients forming and operating accountable care organizations (ACOs), including commercial ACOs and those in the Medicare Pioneer Program and Medicare Shared Savings Program ACOs.
Charlie focuses his regulatory practice on federal fraud and abuse laws (including the Stark Law), obtaining and maintaining tax-exemption, the Health Insurance Portability and Accountability Act (HIPAA) and health information privacy, state insurance licensure and determination of need law, and general corporate matters.
After earning his law degree, Charlie clerked for the Honorable Charles R. Breyer of the US District Court for the Northern District of California. Prior to law school, Charlie served on the professional staff of the United States Senate Finance Committee for Senator Daniel Patrick Moynihan, where he concentrated on health reform and Medicare Part A. He also worked as a policy analyst at the Jackson Hole Group, where he focused on rural healthcare and purchasing cooperatives.
Lawyer Rankings
United States > Healthcare > Service providers
The team at McDermott Will & Emery LLP displays ‘exceptional depth‘ as it advises a host of tech companies, private equity funds, hospitals, and ambulatory and surgical care clients, handling partnerships between service providers and digital tech companies, intellectual property, and governance issues. Jerry Sokol leads the team from Miami as the global head of the healthcare group, while Gary Scott Davis advises major health insurance companies on healthcare joint ventures and reimbursement transactions. In the Chicago office, Bernadette Broccolo has longstanding expertise in issues surrounding healthcare IT and compliance programs for academic medical centers, while Kerrin Slattery is adept at advising health systems and hospitals on transactional matters. Also based in Chicago, Sandra DiVarco is particularly adept at representing clients in restructurings and the legal aspects of clinical issues, and Monica Wallace exhibits both regulatory and transactional expertise when advising on Medicare and Medicaid enrolment, fraud and abuse matters. Charles Buck leads the Boston practice, and primarily handles healthcare transactions, while associate Gregory Fosheim supports the team from Illinois, contributing his expertise in outbreak responses, investment initiatives in clinical research and pharmaceutical procurement.
Lawyer Rankings
Top Tier Firm Rankings
- Media, technology and telecoms > Technology transactions
- Healthcare > Health insurers
- Healthcare > Life sciences
- Media, technology and telecoms > Outsourcing
- Healthcare > Service providers
- Tax > US taxes: contentious
- Tax > US taxes: non-contentious
Firm Rankings
- Insurance > Advice to insurers
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy regulation: electric power
- Tax > Financial products
- Labor and employment > Immigration
- Tax > International tax
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Energy > Renewable/alternative power
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > ERISA litigation
- Dispute resolution > General commercial disputes
- Insurance > Insurance: non-contentious
- Labor and employment > Labor-management relations
- Antitrust > Merger control
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Real estate > Real estate finance
- International Trade > Trade remedies and trade policy
- Labor and employment > Workplace and employment counseling
- Finance > Capital markets: equity offerings
- Antitrust > Cartel
- Antitrust > Civil litigation/class actions: defense
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Labor and employment > Labor and employment disputes (including collective actions)
- Intellectual property > Patents: litigation (full coverage)
- Dispute resolution > Securities litigation: defense
- Finance > Structured finance: derivatives and structured products
- Dispute resolution > Corporate investigations and white-collar criminal defense
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Investment fund formation and management > Alternative/hedge funds
- Government > Government contracts
- Finance > Fintech